Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis.


Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
06 2021
Historique:
received: 02 04 2020
revised: 13 04 2020
accepted: 14 04 2020
pubmed: 26 4 2020
medline: 4 6 2021
entrez: 26 4 2020
Statut: ppublish

Résumé

In this systematic review and meta-analysis, we aimed to explore the association between cardiac injury and mortality, the need for intensive care unit (ICU) care, acute respiratory distress syndrome (ARDS), and severe coronavirus disease 2019 (COVID-19) in patients with COVID-19 pneumonia. We performed a comprehensive literature search from several databases. Definition of cardiac injury follows that of the included studies, which includes highly sensitive cardiac troponin I (hs-cTnl) >99th percentile.The primary outcome was mortality, and the secondary outcomes were ARDS, the need for ICU care, and severe COVID-19. ARDS and severe COVID-19 were defined per the World Health Organization (WHO) interim guidance of severe acute respiratory infection (SARI) of COVID-19. There were a total of 2389 patients from 13 studies. This meta-analysis showed that cardiac injury was associated with higher mortality (RR 7.95 [5.12, 12.34], Cardiac injury is associated with mortality, need for ICU care, and severity of disease in patients with COVID-19.

Sections du résumé

Background
In this systematic review and meta-analysis, we aimed to explore the association between cardiac injury and mortality, the need for intensive care unit (ICU) care, acute respiratory distress syndrome (ARDS), and severe coronavirus disease 2019 (COVID-19) in patients with COVID-19 pneumonia.
Methods
We performed a comprehensive literature search from several databases. Definition of cardiac injury follows that of the included studies, which includes highly sensitive cardiac troponin I (hs-cTnl) >99th percentile.The primary outcome was mortality, and the secondary outcomes were ARDS, the need for ICU care, and severe COVID-19. ARDS and severe COVID-19 were defined per the World Health Organization (WHO) interim guidance of severe acute respiratory infection (SARI) of COVID-19.
Results
There were a total of 2389 patients from 13 studies. This meta-analysis showed that cardiac injury was associated with higher mortality (RR 7.95 [5.12, 12.34],
Conclusion
Cardiac injury is associated with mortality, need for ICU care, and severity of disease in patients with COVID-19.

Identifiants

pubmed: 32331955
pii: S0735-6757(20)30280-1
doi: 10.1016/j.ajem.2020.04.052
pmc: PMC7166308
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

352-357

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2020 Elsevier Inc. All rights reserved.

Références

JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Clin Virol. 2020 Jun;127:104364
pubmed: 32311650
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Infect Dis Clin North Am. 2019 Dec;33(4):869-889
pubmed: 31668196
Ann Intern Med. 2015 Jun 2;162(11):777-84
pubmed: 26030634
Circulation. 2009 May 19;119(19):2615-24
pubmed: 19451363
Clin Infect Dis. 2020 Nov 19;71(16):2089-2098
pubmed: 32361738
Microbiol Mol Biol Rev. 2012 Mar;76(1):16-32
pubmed: 22390970
Eur Heart J. 2021 Jan 7;42(2):206
pubmed: 32176300
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Circ Res. 2016 Feb 5;118(3):496-514
pubmed: 26846643
Cardiovasc Res. 2020 May 1;116(6):1097-1100
pubmed: 32227090
Respir Res. 2020 Jun 11;21(1):146
pubmed: 32527255
Clin Res Cardiol. 2020 May;109(5):531-538
pubmed: 32161990
Anaesthesist. 2020 Apr;69(4):225-235
pubmed: 32189015
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Cell Mol Immunol. 2020 Jun;17(6):613-620
pubmed: 32203189
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556

Auteurs

Anwar Santoso (A)

Department of Cardiology - Vascular Medicine, Universitas Indonesia, Harapan Kita Hospital - National Cardiovascular Centre, Jalan Letjen S. Parman kav 87, Jakarta 11420, Indonesia. Electronic address: anwarsantoso@inaheart.org.

Raymond Pranata (R)

Faculty of Medicine, Universitas Pelita Harapan, MH Thamrin Boulevard 1100, Tangerang 15811, Indonesia.

Arief Wibowo (A)

Department of Cardiology - Vascular Medicine, Padjadjaran University, Dr. Hasan Sadikin Hospital, Jalan Pasteur No: 38, Bandung 40161, Indonesia.

Makhyan Jibril Al-Farabi (MJ)

Department of Cardiology - Vascular Medicine, Airlangga University, Soetomo Academic and General Hospital, Jalan Mayjen Moestopo No: 6-8, Surabaya 60286, Indonesia. Electronic address: m.farabi.17@ucl.ac.uk.

Ian Huang (I)

Faculty of Medicine, Universitas Pelita Harapan, MH Thamrin Boulevard 1100, Tangerang 15811, Indonesia.

Budhi Antariksa (B)

Department of Pulmonology and Respiratory Medicine, Universitas Indonesia, Persahabatan Hospital, Jalan Persahabatan Raya No: 1, Jakarta 13230, Indonesia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH